<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN" "http://jats.nlm.nih.gov/publishing/1.0/JATS-journalpublishing1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="1.0" xml:lang="en">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">SANP</journal-id>
      <journal-title-group>
        <journal-title>Swiss Archives of Neurology, Psychiatry and Psychotherapy</journal-title>
      </journal-title-group>
      <issn pub-type="epub">2297-7007</issn>
      <issn pub-type="ppub">2297-6981</issn>
      <publisher>
        <publisher-name>EMH Schweizerischer Ärzteverlag AG</publisher-name>
        <publisher-loc>Farnsburgerstrasse 8
CH-4132 Muttenz</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id">03213</article-id>
      <article-id pub-id-type="doi">10.4414/sanp.2021.03213</article-id>
      <article-categories>
        <!-- rubric -->
        <subj-group subj-group-type="Article Type">
          <subject>Clinical research highlight</subject>
        </subj-group>
        <!-- topics -->
        <subj-group subj-group-type="Classification">
          <subject>Psychotherapy</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Stage-specific interventions for emotion dysregulation disorders in adolescents</article-title>
      </title-group>
      <contrib-group>
        <contrib id="author-1" contrib-type="author" corresp="yes">
          <contrib-id contrib-id-type="orcid"/>
          <name>
            <surname>Ivanova</surname>
            <given-names>Vladimira</given-names>
          </name>
          <email>vladimira.ivanova@unige.ch</email>
          <aff>Research assistant | Psychiatry Departement | Campus Biotech, Chemin des Mines, 9 | Geneva | 1202 | SWITZERLAND</aff>
        </contrib>
        <contrib id="author-2" contrib-type="author" corresp="no">
          <contrib-id contrib-id-type="orcid"/>
          <name>
            <surname>Celen</surname>
            <given-names>Zeynep</given-names>
          </name>
          <email/>
          <aff>1)Psychiatry Department, Faculty of Medicine, University of Geneva, Switzerland
2)Department of Neurosciences, Faculty of Medicine, University of Geneva, Switzerland</aff>
        </contrib>
        <contrib id="author-3" contrib-type="author" corresp="no">
          <contrib-id contrib-id-type="orcid"/>
          <name>
            <surname>Piguet</surname>
            <given-names>Camille</given-names>
          </name>
          <email/>
          <aff>1)Psychiatry Department, Faculty of Medicine, University of Geneva, Switzerland
3)Malatavie Crisis Unit, Child and Adolescent Psychiatry Division, Geneva University Hospi</aff>
        </contrib>
      </contrib-group>
      <pub-date pub-type="epub" date-type="pub" iso-8601-date="2021.07.19">
        <day>19</day>
        <month>07</month>
        <year>2021</year>
      </pub-date>
      <volume>172</volume>
      <issue>04</issue>
      <fpage>0</fpage>
      <lpage>0</lpage>
      <permissions>
        <copyright-statement>Copyright: EMH Schweizerischer Ärzteverlag AG</copyright-statement>
        <copyright-year>2021</copyright-year>
        <copyright-holder>EMH Schweizerischer Ärzteverlag AG</copyright-holder>
        <license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
          <license-p>"Swiss Archives of Neurology, Psychiatry and Psychotherapy" is an open access publication of EMH published in accordance with the terms of the Creative Commons licence attribution - NonCommercial - NoDerivatives 4.0 International. You are free to share, copy and redistribute the material in any medium or format under the following terms:</license-p>
          <license-p>Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.</license-p>
          <license-p>NonCommercial — You may not use the material for commercial purposes.</license-p>
          <license-p>NoDerivatives — If you remix, transform, or build upon the material, you may not distribute the modified material.</license-p>
          <license-p>"Non-commercial" means not primarily intended for or directed towards commercial advantage or monetary compensation. The incorporation of publications in commercial products, the use of publications to advertise for commercial products or services and any other usage that directly or indirectly pursues commercial interests is subject to the express previous consent of the publishing house as part of a written agreement.</license-p>
          <license-p>Please send us your request in writing. Exact indication of the publication from which you would like to reproduce material and detailed information about its intended use help to facilitate and expedite request processing.</license-p>
        </license>
      </permissions>
      <abstract abstract-type="article" xml:lang="en">
        <p>Since most of the early signs of psychological distress are nonspecific and often under the threshold of a diagnosable disorder, especially in early adolescence, a dimensional and transdiagnostic approach is needed to guide early interventions. In this review, we focus on the transdiagnostic mechanism of  emotion dysregulation  hypothesized to underlie a group of psychopathologies that we named “emotion dysregulation disorders”. Some promising interventions useful at different stages of the evolution of such disorders (from subclinical to clinical ones) are briefly presented. Among them, we propose Cognitive-Behavioral therapies, Mindfulness-Based Interventions, and Mentalization-Based Treatment. The MBIs are an essential part of our ongoing study on the effects of an 8-weeks regular practice of Mindfulness on non-clinical adolescents between 13 and 15 years old. We finally conclude with a proposition of a potential clinical staging model for emotion dysregulation disorders.</p>
      </abstract>
    </article-meta>
  </front>
  <body/>
  <back/>
</article>
